- Home
- XCUR vs BYSI Comparison
XCUR vs BYSI Comparison
Compare XCUR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- BYSI
- Stock Information
- Founded
- XCUR 2011
- BYSI 2010
- Country
- XCUR United States
- BYSI United States
- Employees
- XCUR N/A
- BYSI N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- XCUR Health Care
- BYSI Health Care
- Exchange
- XCUR Nasdaq
- BYSI Nasdaq
- Market Cap
- XCUR 67.8M
- BYSI 67.3M
- IPO Year
- XCUR N/A
- BYSI 2017
- Fundamental
- Price
- XCUR $9.88
- BYSI $1.73
- Analyst Decision
- XCUR
- BYSI
- Analyst Count
- XCUR 0
- BYSI 0
- Target Price
- XCUR N/A
- BYSI N/A
- AVG Volume (30 Days)
- XCUR 11.5K
- BYSI 20.0K
- Earning Date
- XCUR 06-16-2025
- BYSI 05-12-2025
- Dividend Yield
- XCUR N/A
- BYSI N/A
- EPS Growth
- XCUR N/A
- BYSI N/A
- EPS
- XCUR N/A
- BYSI N/A
- Revenue
- XCUR $500,000.00
- BYSI N/A
- Revenue This Year
- XCUR N/A
- BYSI N/A
- Revenue Next Year
- XCUR N/A
- BYSI N/A
- P/E Ratio
- XCUR N/A
- BYSI N/A
- Revenue Growth
- XCUR N/A
- BYSI N/A
- 52 Week Low
- XCUR $1.44
- BYSI $0.98
- 52 Week High
- XCUR $36.00
- BYSI $2.97
- Technical
- Relative Strength Index (RSI)
- XCUR 42.90
- BYSI 54.43
- Support Level
- XCUR $9.01
- BYSI $1.62
- Resistance Level
- XCUR $10.00
- BYSI $1.77
- Average True Range (ATR)
- XCUR 0.39
- BYSI 0.08
- MACD
- XCUR -0.04
- BYSI -0.00
- Stochastic Oscillator
- XCUR 36.53
- BYSI 70.53
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.